| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1917479 | Maturitas | 2012 | 6 Pages |
Abstract
In our data, we did not observe an association between the decline in HRT prescription and breast cancer incidence among women aged from 50 to 69 years. The lack of temporal changes in breast cancer incidence may be explained by introduction of opportunistic and organized mammography screening and low absolute levels of HRT prescription in Germany.
Keywords
MWSDCOESPMCRHRTDDDAPCNHANESICD-1095%CIhERsInternational Agency for Research on CancerIARC یا International Agency for Research on CancerWomen's Health InitiativeIncidenceDefined daily dosesCancer registryBreast cancerSEER95% confidence intervalSurveillance, Epidemiology, and End Resultshormone replacement therapywhiDeath certificate onlyEstrogen receptorestrogen receptorshormone receptorProgesterone receptorsProgesterone receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Carsten Rusner, Ulrike Bandemer-Greulich, Jutta Engel, Christa Stegmaier, Anette Zawinell, Bernd Holleczek, Alexander Katalinic, Oliver Kuss, Andrea Schmidt-Pokrzywniak, Gabriele Schubert-Fritschle, Anett Tillack, Andreas Stang,